Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

PubWeight™: 4.26‹?› | Rank: Top 1%

🔗 View Article (PMC 319576)

Published in Proc Natl Acad Sci U S A on June 01, 1981

Authors

R A Lerner, N Green, H Alexander, F T Liu, J G Sutcliffe, T M Shinnick

Articles citing this

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A (1984) 7.77

Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res (1983) 4.94

Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J (1982) 3.32

A rat monoclonal antibody reacting specifically with the tyrosylated form of alpha-tubulin. I. Biochemical characterization, effects on microtubule polymerization in vitro, and microtubule polymerization and organization in vivo. J Cell Biol (1983) 2.61

Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A (1982) 2.52

The methionine-rich domain of the 54 kd protein subunit of the signal recognition particle contains an RNA binding site and can be crosslinked to a signal sequence. EMBO J (1990) 2.35

OCH1 encodes a novel membrane bound mannosyltransferase: outer chain elongation of asparagine-linked oligosaccharides. EMBO J (1992) 2.29

Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus. J Virol (1983) 2.24

Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide. Proc Natl Acad Sci U S A (1982) 2.18

Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. Proc Natl Acad Sci U S A (1983) 2.00

Antibodies specific to acetylated histones document the existence of deposition- and transcription-related histone acetylation in Tetrahymena. J Cell Biol (1989) 1.91

On the nature of crossreactions observed with antibodies directed to defined epitopes. Proc Natl Acad Sci U S A (1982) 1.89

A general strategy for cloning double-stranded RNA: nucleotide sequence of the Simian-11 rotavirus gene 8. Nucleic Acids Res (1982) 1.83

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A (1982) 1.81

Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A (1991) 1.77

Characterization of a mammalian homolog of the Escherichia coli MutY mismatch repair protein. Mol Cell Biol (1995) 1.75

Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing the gene order of measles virus. J Virol (1985) 1.75

Purification of polyoma virus medium-size tumor antigen by immunoaffinity chromatography. Proc Natl Acad Sci U S A (1982) 1.74

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A (1986) 1.74

Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol (1986) 1.73

Peptide antibody specific for the amino terminus of skeletal muscle alpha-actin. Proc Natl Acad Sci U S A (1983) 1.63

T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. J Virol (1999) 1.53

Isoforms of the Na,K-ATPase are present in both axons and dendrites of hippocampal neurons in culture. Proc Natl Acad Sci U S A (1992) 1.42

Expression of hepatitis B virus surface antigen in yeast. Nucleic Acids Res (1983) 1.39

A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36

Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen. Proc Natl Acad Sci U S A (1982) 1.33

Antibody directed to determinants of a Moloney virus derived MCF GP70 recognizes a thymic differentiation antigen. J Exp Med (1983) 1.32

Identification of a peptide sequence involved in homophilic binding in the neural cell adhesion molecule NCAM. J Cell Biol (1992) 1.32

Primary structure of a human arginine-rich nuclear protein that colocalizes with spliceosome components. Proc Natl Acad Sci U S A (1991) 1.29

A cadherin-like protein in eggs and cleaving embryos of Xenopus laevis is expressed in oocytes in response to progesterone. J Cell Biol (1990) 1.27

N2,N2-dimethylguanosine-specific tRNA methyltransferase contains both nuclear and mitochondrial targeting signals in Saccharomyces cerevisiae. J Cell Biol (1989) 1.27

Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin. Proc Natl Acad Sci U S A (1983) 1.26

Successful immunization with a totally synthetic diphtheria vaccine. Proc Natl Acad Sci U S A (1982) 1.26

Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc Natl Acad Sci U S A (1989) 1.25

Priorities for immunisation against hepatitis B. Br Med J (Clin Res Ed) (1982) 1.24

Viral hepatitis. Bull World Health Organ (1982) 1.23

Multiple genes coding for precursors of rhodotorucine A, a farnesyl peptide mating pheromone of the basidiomycetous yeast Rhodosporidium toruloides. Mol Cell Biol (1989) 1.21

Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus. Proc Natl Acad Sci U S A (1995) 1.19

Anti-peptide antibodies detect oncogene-related proteins in urine. Proc Natl Acad Sci U S A (1985) 1.18

Antibodies of predetermined specificity detect two retroviral oncogene products and inhibit their kinase activities. Proc Natl Acad Sci U S A (1983) 1.17

Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitro. J Virol (1982) 1.17

First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol (1994) 1.17

Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochem J (1995) 1.17

Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus. J Virol (1986) 1.15

Detection of fos protein during osteogenesis by monoclonal antibodies. Mol Cell Biol (1988) 1.15

An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity. Proc Natl Acad Sci U S A (1985) 1.11

Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions. Biochem J (1994) 1.11

Biosynthesis of human fibroblast growth factor-5. Mol Cell Biol (1991) 1.09

Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol (1994) 1.07

Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J (1992) 1.06

Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays. Mol Cell Proteomics (2014) 1.03

An antibody to a synthetic peptide that recognises SV40 small-t antigen. EMBO J (1982) 1.03

Metallothionein: structure/antigenicity and detection/quantitation in normal physiological fluids. Environ Health Perspect (1984) 1.02

The ras-like protein p25rab3A is partially cytosolic and is expressed only in neural tissue. Mol Cell Biol (1989) 1.02

Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen. J Virol (1993) 1.02

Proteins encoded by the long terminal repeat region of mouse mammary tumor virus: identification by hybrid-selected translation. J Virol (1984) 1.01

Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J Virol (1995) 1.00

Purification of immature cores of mouse mammary tumor virus and immunolocalization of protein domains. J Virol (1992) 1.00

Production of specific antibodies against protein A fusion proteins. EMBO J (1986) 0.97

Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions. Clin Exp Immunol (1988) 0.96

Carcinoembryonic antigen family: expression in a mouse L-cell transfectant and characterization of a partial cDNA in bacteriophage lambda gt11. Proc Natl Acad Sci U S A (1987) 0.96

Expression and purification of the mouse mammary tumor virus gag-pro transframe protein p30 and characterization of its dUTPase activity. J Virol (1994) 0.95

Proteolytic footprinting of transcription factor TFIIIA reveals different tightly binding sites for 5S RNA and 5S DNA. Mol Cell Biol (1993) 0.94

Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. Proc Natl Acad Sci U S A (1989) 0.94

Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I. J Virol (1991) 0.94

Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens. Infect Immun (1984) 0.93

Immunological castration of male mice by a totally synthetic vaccine administered in saline. Proc Natl Acad Sci U S A (1982) 0.92

Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s. Proc Natl Acad Sci U S A (1983) 0.88

The development of novel hepatitis B vaccines. Bull World Health Organ (1987) 0.88

Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides. J Virol (1992) 0.87

Antibodies against synthetic oligopeptides allow identification of the mRNA-maturase encoded by the second intron of the yeast cob-box gene. EMBO J (1984) 0.86

Production and characterization of an Mls-1-specific monoclonal antibody. J Exp Med (1993) 0.85

Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide. J Virol (1983) 0.84

Developmentally regulated rpd3p homolog specific to the transcriptionally active macronucleus of vegetative Tetrahymena thermophila. Mol Cell Biol (2000) 0.84

Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 0.84

New hepatitis B vaccines. Br Med J (Clin Res Ed) (1985) 0.79

Expression of c-myc oncogene in coeliac disease. J Clin Pathol (1987) 0.79

Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med (1984) 0.78

Structural analysis of the carboxy terminus of bacteriophage lambda repressor determined by antipeptide antibodies. J Bacteriol (1989) 0.76

Site-specific antibodies to human erythropoietin directed toward the NH2-terminal region. Proc Natl Acad Sci U S A (1983) 0.75

Defective antigen presentation by monocytes in ESRD patients not responding to hepatitis B vaccination: impaired HBsAg internalization and expression of ICAM-1 and HLA-DR/Ia molecules. Mediators Inflamm (1995) 0.75

Expression of antigenic regions of a trypanosome variable surface glycoprotein in E. coli using Bal-31 nuclease digestion. Nucleic Acids Res (1984) 0.75

Articles cited by this

Tissue sulfhydryl groups. Arch Biochem Biophys (1959) 61.89

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (1979) 15.42

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet (1970) 11.61

Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83

Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature (1979) 6.10

New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02

Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature (1980) 4.35

Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1980) 4.04

Chemical synthesis of peptides and proteins. Annu Rev Biochem (1970) 2.78

Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34

An immunologic approach to the conformational equilibria of polypeptides. Proc Natl Acad Sci U S A (1972) 1.85

Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide. Nature (1981) 1.85

Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science (1972) 1.72

Proteins of hepatitis B surface antigen. J Virol (1977) 1.71

A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles. J Immunol (1980) 1.50

Australia antigen (a hepatitis-associated antigen): purification and physical properties. J Exp Med (1970) 1.46

Chemically defined antiviral vaccines. Annu Rev Microbiol (1980) 1.41

Hepatitis B surface antigen polypeptides: artifactual bands in sodium dodecyl sulfate-polyacrylamide gel electrophoresis caused by aggregation. J Virol (1980) 1.20

Articles by these authors

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol (1993) 45.22

Complete nucleotide sequence of the Escherichia coli plasmid pBR322. Cold Spring Harb Symp Quant Biol (1979) 43.48

Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82

Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci U S A (1978) 19.34

Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol (1988) 13.78

pBR322 restriction map derived from the DNA sequence: accurate DNA size markers up to 4361 nucleotide pairs long. Nucleic Acids Res (1978) 13.22

The structure of an antigenic determinant in a protein. Cell (1984) 10.85

Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci (1998) 9.88

The 65-kilodalton antigen of Mycobacterium tuberculosis. J Bacteriol (1987) 9.50

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature (1996) 8.99

Immunogenic structure of the influenza virus hemagglutinin. Cell (1982) 8.93

Mitotic misregulation and human aging. Science (2000) 8.47

Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein. J Biol Chem (1977) 8.03

The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81

Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. Proc Natl Acad Sci U S A (1977) 6.80

Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69

Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol (1993) 6.65

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A (1991) 5.94

Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science (1989) 5.73

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50

Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol (1992) 5.20

Tapping the immunological repertoire to produce antibodies of predetermined specificity. Nature (1982) 5.11

New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02

p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA (1988) 4.89

Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A (1983) 4.56

Hybridization of labeled RNA to DNA in agarose gels. Nucleic Acids Res (1975) 4.38

Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature (1980) 4.35

Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family. Nature (1977) 4.31

A restriction enzyme Tha I from the thermophilic mycoplasma Thermoplasma acidophilum. Nucleic Acids Res (1978) 4.25

Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med (1995) 4.10

The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein. Nature (1984) 4.05

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay. J Clin Microbiol (1990) 4.04

Encoded combinatorial chemistry. Proc Natl Acad Sci U S A (1992) 4.00

Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol (1994) 3.85

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes. Science (1995) 3.82

Access to genitourinary medicine clinics in the United Kingdom. Sex Transm Infect (2001) 3.79

The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1994) 3.78

Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med (1983) 3.52

Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51

Function of the thick ascending limb of Henle's loop. Am J Physiol (1973) 3.48

Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study. Crit Care Med (1993) 3.46

Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol (1988) 3.32

Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature (1989) 3.31

Rapid, amplification-based fingerprinting of Mycobacterium tuberculosis. J Gen Microbiol (1993) 3.19

Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc Natl Acad Sci U S A (1981) 3.13

Furosemide effect on isolated perfused tubules. Am J Physiol (1973) 2.95

Nucleotide sequence of Moloney leukemia virus: 3' end reveals details of replications, analogy to bacterial transposons, and an unexpected gene. Proc Natl Acad Sci U S A (1980) 2.90

Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A (1996) 2.85

Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature (1982) 2.84

Antibody catalysis of the oxidation of water. Science (2001) 2.74

Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome. J Virol (1986) 2.71

Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71

Chemical characterization of a family of brain lipids that induce sleep. Science (1995) 2.69

The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG. Infect Immun (1987) 2.66

The cleavage site of the restriction endonuclease Ava II. Nucleic Acids Res (1978) 2.60

Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55

Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature (1984) 2.52

Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci U S A (1991) 2.42

Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J Exp Med (1966) 2.42

An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell (1996) 2.42

An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Proc Natl Acad Sci U S A (1986) 2.42

Catalytic antibodies. Science (1986) 2.41

Gene expression in rat brain. Nucleic Acids Res (1983) 2.40

Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40

Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proc Natl Acad Sci U S A (1984) 2.40

The human retinal degeneration slow (RDS) gene: chromosome assignment and structure of the mRNA. Genomics (1991) 2.39

A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother (1993) 2.39

Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J Exp Med (1980) 2.38

The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med (1975) 2.37

Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J Mol Biol (1988) 2.33

Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J Mol Biol (1988) 2.30

Turnaround times for mycobacterial cultures. J Clin Microbiol (1997) 2.30

Mature microglia resemble immature antigen-presenting cells. Glia (1998) 2.28

Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Science (1997) 2.27

Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron (1990) 2.26

Conformation of peptide fragments of proteins in aqueous solution: implications for initiation of protein folding. Biochemistry (1988) 2.21

Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol (1996) 2.13